Bronchiectasis—a clinical review

AE O'Donnell - New England Journal of Medicine, 2022 - Mass Medical Soc
Bronchiectasis — A Clinical Review | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Physiology and pathophysiology of human airway mucus

DB Hill, B Button, M Rubinstein… - Physiological …, 2022 - journals.physiology.org
The mucus clearance system is the dominant mechanical host defense system of the human
lung. Mucus is cleared from the lung by cilia and airflow, including both two-phase gas-liquid …

Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

JD Chalmers, E Polverino, ML Crichton… - The Lancet …, 2023 - thelancet.com
Background Bronchiectasis is a heterogeneous, neglected disease with few multicentre
studies exploring the causes, severity, microbiology, and treatment of the disease across …

[HTML][HTML] Bronchiectasis management in adults: state of the art and future directions

H Choi, PJ McShane, S Aliberti… - European Respiratory …, 2024 - publications.ersnet.org
Formerly regarded as a rare disease, bronchiectasis is increasingly recognised. A renewed
interest in this disease has led to significant progress in bronchiectasis research …

Treatable traits in the NOVELTY study

A Agustí, E Rapsomaniki, R Beasley, R Hughes… - …, 2022 - Wiley Online Library
Background and objective Asthma and chronic obstructive pulmonary disease (COPD) are
two prevalent and complex diseases that require personalized management. Although a …

Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

A Spinou, B Hererro-Cortina, S Aliberti… - European …, 2024 - publications.ersnet.org
Background International guidelines recommend airway clearance management as one of
the important pillars of bronchiectasis treatment. However, the extent to which airway …

[HTML][HTML] Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis

A Shoemark, H Griffin, G Wheway… - European …, 2022 - publications.ersnet.org
Background Bronchiectasis can result from infectious, genetic, immunological and allergic
causes. 60–80% of cases are idiopathic, but a well-recognised genetic cause is the motile …

Infection and the microbiome in bronchiectasis

M Mac Aogáin, AJ Dicker, P Mertsch… - European …, 2024 - publications.ersnet.org
Bronchiectasis is marked by bronchial dilatation, recurrent infections and significant
morbidity, underpinned by a complex interplay between microbial dysbiosis and immune …

[HTML][HTML] Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis

M Conceição, M Shteinberg… - European …, 2024 - publications.ersnet.org
Introduction: Pseudomonas aeruginosa is the most commonly isolated pathogen in
bronchiectasis and is associated with worse outcomes. Eradication treatment is …

Artificial intelligence–based CT assessment of bronchiectasis: the COPDGene Study

AA Díaz, P Nardelli, W Wang, R San José Estépar… - Radiology, 2022 - pubs.rsna.org
Background CT is the standard method used to assess bronchiectasis. A higher airway-to-
artery diameter ratio (AAR) is typically used to identify enlarged bronchi and bronchiectasis; …